Grastim 300 mcg/0.5 ml IV/SC InjectionIndication:1. Cancer patients receiving myelosuppressive chemotherapy:Filgrastim is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs ass..